PURPOSE: Tumor cells are known to express hypoxia-related proteins such as glucose transporter-1 (Glut-1). These hypoxia-induced changes may allow tumor cells to survive under sustained hypoxic microenvironments, and the surviving tumor cell under hypoxia may develop a more aggressive phenotype and so result in a poor prognosis. MATERIALS AND METHODS: The Glut-1 expression was analyzed by immunohistochemistry, and its association with the prognosis was assessed in 60 patients with squamous cell carcinoma of the tongue. RESULTS: The Glut-1 expression was diffuse with a membranous pattern, and the median percentage of Glut-1 positive tumor cells was 60% (range: 0.0 approximately 90.0%). A high Glut-1 expression (the percentage of positive tumor cells >or= the median value, 60%) was associated with the location of primary lesion, lymph node metastasis status and disease stage (p<0.05). The expression of Glut-1 was correlated with the Ki-67 expression (r=0.406, p=0.001). Microvessel density, as represented by CD31 staining, was also correlated with the Glut-1 expression although its significance is weak (r=0.267, p=0.039). On the univariate analysis, the group with a high Glut-1 expression showed poorer overall survival than the group with a low Glut-1 expression (p<0.05). However, the Glut-1 expression failed to show any independent prognostic significance on the multivariate analysis. CONCLUSION: The expression of Glut-1 may be useful for predicting the prognosis and determining the treatment strategy for the management of squamous cell carcinoma of the tongue.
PURPOSE:Tumor cells are known to express hypoxia-related proteins such as glucose transporter-1 (Glut-1). These hypoxia-induced changes may allow tumor cells to survive under sustained hypoxic microenvironments, and the surviving tumor cell under hypoxia may develop a more aggressive phenotype and so result in a poor prognosis. MATERIALS AND METHODS: The Glut-1 expression was analyzed by immunohistochemistry, and its association with the prognosis was assessed in 60 patients with squamous cell carcinoma of the tongue. RESULTS: The Glut-1 expression was diffuse with a membranous pattern, and the median percentage of Glut-1 positive tumor cells was 60% (range: 0.0 approximately 90.0%). A high Glut-1 expression (the percentage of positive tumor cells >or= the median value, 60%) was associated with the location of primary lesion, lymph node metastasis status and disease stage (p<0.05). The expression of Glut-1 was correlated with the Ki-67 expression (r=0.406, p=0.001). Microvessel density, as represented by CD31 staining, was also correlated with the Glut-1 expression although its significance is weak (r=0.267, p=0.039). On the univariate analysis, the group with a high Glut-1 expression showed poorer overall survival than the group with a low Glut-1 expression (p<0.05). However, the Glut-1 expression failed to show any independent prognostic significance on the multivariate analysis. CONCLUSION: The expression of Glut-1 may be useful for predicting the prognosis and determining the treatment strategy for the management of squamous cell carcinoma of the tongue.
Authors: Michael I Koukourakis; Søren M Bentzen; Alexandra Giatromanolaki; George D Wilson; Frances M Daley; Michele I Saunders; Stanley Dische; Efthimios Sivridis; Adrian L Harris Journal: J Clin Oncol Date: 2006-01-17 Impact factor: 44.544
Authors: Seok Jin Kim; Zahid N Rabbani; Robin T Vollmer; Ernst-Gilbert Schreiber; Egbert Oosterwijk; Mark W Dewhirst; Zeljko Vujaskovic; Michael J Kelley Journal: Clin Cancer Res Date: 2004-12-01 Impact factor: 12.531
Authors: M I Koukourakis; A Giatromanolaki; E Sivridis; K Simopoulos; J Pastorek; C C Wykoff; K C Gatter; A L Harris Journal: Clin Cancer Res Date: 2001-11 Impact factor: 12.531
Authors: Daniel E B Swinson; J Louise Jones; Donna Richardson; Charles Wykoff; Helen Turley; Jaromir Pastorek; Nick Taub; Adrian L Harris; Kenneth J O'Byrne Journal: J Clin Oncol Date: 2003-02-01 Impact factor: 44.544
Authors: Martin Kunkel; Torsten E Reichert; Peter Benz; Hans-Anton Lehr; Jong-Hyeon Jeong; Samuel Wieand; Peter Bartenstein; Wilfried Wagner; Theresa L Whiteside Journal: Cancer Date: 2003-02-15 Impact factor: 6.860
Authors: Anna S E Ljungkvist; Johan Bussink; Paulus F J W Rijken; Johannes H A M Kaanders; Albert J van der Kogel; Juliana Denekamp Journal: Int J Radiat Oncol Biol Phys Date: 2002-09-01 Impact factor: 7.038
Authors: Rachel E Airley; Juliette Loncaster; James A Raleigh; Adrian L Harris; Susan E Davidson; Robert D Hunter; Catharine M L West; Ian J Stratford Journal: Int J Cancer Date: 2003-03-10 Impact factor: 7.396
Authors: Eivind Smeland; Thomas K Kilvaer; Sveinung Sorbye; Andrej Valkov; Sigve Andersen; Roy M Bremnes; Lill-Tove Busund; Tom Donnem Journal: Sarcoma Date: 2012-02-20